Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
| Revenue (Most Recent Fiscal Year) | $1.31B |
| Net Income (Most Recent Fiscal Year) | $117.56M |
| PE Ratio (Current Year Earnings Estimate) | 20.98 |
| PE Ratio (Trailing 12 Months) | 24.24 |
| PEG Ratio (Long Term Growth Estimate) | 1.75 |
| Price to Sales Ratio (Trailing 12 Months) | 3.74 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.10 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 16.11 |
| Pre-Tax Margin (Trailing 12 Months) | 11.60% |
| Net Margin (Trailing 12 Months) | 8.98% |
| Return on Equity (Trailing 12 Months) | 22.25% |
| Return on Assets (Trailing 12 Months) | 9.73% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.56 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.50 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.83 |
| Inventory Turnover (Trailing 12 Months) | 2.06 |
| Book Value per Share (Most Recent Fiscal Quarter) | $18.90 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.90 |
| Earnings per Share (Most Recent Fiscal Year) | $3.96 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.29 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 50.79M |
| Free Float | 49.88M |
| Market Capitalization | $4.90B |
| Average Volume (Last 20 Days) | 0.52M |
| Beta (Past 60 Months) | 0.34 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.79% |
| Percentage Held By Institutions (Latest 13F Reports) | 99.67% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |